Research

The Translational Neurotherapeutics Program brings together basic scientists and clinicians to establish effective pathways for bringing medicines for neurodegenerative diseases from the lab to the clinic.

Dr. Ullman’s research investigates the neural and computational bases of language, how language and memory are affected in various disorders, and how certain factors affect language and memory.

The Center for Aphasia Research and Rehabilitation (CARR) brings together professionals with the goal of integrating their research findings on stroke, aphasia, and normal cognition for better treatments.

The lab aims to develop better treatment for people with cognitive and language difficulties through expanding knowledge of these areas: specifically how they change with injury, illness, and recovery.

The main aim of the Collaborative for Research on Outcomes and -Metrics (CRΘM) is to change the way that biomedical data are analyzed using methods from psychometrics, neuropsychometrics and biometrics.

Dr. Motamedi’s clinical research focuses on seizure onset localization and brain mapping for epilepsy surgery while his basic research focuses on the mechanism of action of epilepsy and the effects of hypothermia in seizures.

Our Lab uses a variety of techniques to provide new insights into the integrative mechanisms of cognitive functions and how those processes and mechanisms are disturbed in neurological diseases.

The Georgetown Brain Bank is an invaluable resource that allows the research community to access tissue and biofluid for research and post-mortem evaluation of patients with neurological disorders.

Dr. Golestaneh’s lab is investigating how aging mechanisms affect the cells and induce diseases such as age-related macular degeneration (AMD).

Dr. Harris’ research focuses on the areas of neurodegeneration and CNS neoplasia. His primary interest is in understanding neuroinflammation and glial-neuronal communication in neurological diseases.

The new Huntington’s Disease Care, Education, and Research Center uses a multidisciplinary approach to the treatment of patients and their families in the spirit of cura personalis, the care of the whole person.

GUH is a participant in the International Pediatric Stroke Study (IPSS). The purpose of this research is to learn more about the natural history of childhood stroke.

The Learning and Development is studies the acquisition of language, the relationship between language acquisition and language structure, and the recovery of language after damage to the brain.

The Georgetown University Memory Disorders Program is dedicated to providing clinical services for patients with Memory Disorders and to conducting research aimed at improving treatment options for Alzheimer’s disease.

Dr. Kanwal studies the brain wiring of socioemotional communication and decision making. He focuses specifically on hemispheric asymmetry, circuit/ neuron multifunctional, and fronto-amygdalar interactions.

The laboratory evaluates potential therapeutic drugs in pre-clinical and clinical trials for neurodegenerative diseases including dementia, Alzheimer’s disease, Parkinson’s disease and related movement disorders.